Probucol

From Wikipedia, the free encyclopedia

Probucol
Systematic (IUPAC) name
2,6-ditert-butyl-4-[2-(3,5-ditert-butyl-4-hydroxyphenyl) sulfanylpropan-2-ylsulfanyl]phenol
Identifiers
CAS number 23288-49-5
ATC code C10AX02
PubChem 4912
Chemical data
Formula C31H48O2S2 
Mol. mass 516.844 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Probucol is an anti-hyperlipidemic drug initially developed in the treatment of coronary artery disease. However, clinical trials were stopped after it was found that it causes Long QT syndrome in patients.

[edit] Mechanism

Probucol lowers the level of cholesterol in the bloodstream by increasing the rate of LDL catabolism. Additionally, probucol may inhibit cholesterol synthesis and delay cholesterol absorption [1]. Probucol is a powerful antioxidant which inhibits the oxidation of cholesterol in LDLs; this slows the formation of foam cells, which contribute to atherosclerotic plaques.

[edit] References

  1. ^ "Probucol. Drugs.com web site. [[1]]